Randomised controlled trial · 2015
Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial
Paduch DA, Polzer PK, Ni X, Basaria S (2015). Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2014-4434
In a 16-week randomised trial of 76 men with low testosterone and ejaculation problems such as delayed ejaculation or reduced volume, testosterone solution did not improve ejaculatory function more than placebo.
Summary
This double-blind, placebo-controlled trial at centres in the US, Canada and Mexico enrolled 76 men with two total testosterone readings below 300 ng/dL (10.41 nmol/L) and at least one ejaculation problem: delayed ejaculation, no ejaculation, reduced ejaculate volume or reduced force. They applied either a 2% testosterone solution or a placebo daily for 16 weeks; 66 completed the study.
Ejaculatory function scores improved slightly in both groups (+3.1 with testosterone, +2.5 with placebo), and the difference was not statistically significant. There were also no differences in measured ejaculate volume, orgasm scores or side effects.
Limitations
The trial was relatively small and short, it was funded by the manufacturer, and it studied slow or weak ejaculation, not premature ejaculation.
What it means for you
Even in men with genuinely low testosterone, topping it up did not fix ejaculation problems better than a placebo in this trial. Testosterone therapy is a treatment for confirmed testosterone deficiency, not a treatment for ejaculation timing.